Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Jul 24, 2015 1:38pm
90 Views
Post# 23957548

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...
ROTFLMAO..hioty toity personally i hope you go bankrupt over RVX given the lies you have posted here...but to help others out...what is the objective of RVX, get 208 on the market or create wealth ....

..IMO the current leadership of RVX has proven itself todate incompetent to task, which leaves me with little hope that unless leadership canges the final outcome will change..

..re. science it is fraudsterism for any non-RVX to claim any real knowledge of 208 (one of the most fraud stances of posters is to claim that kinda knowledge)..you may believe in the potential of 208 but no one knows the science and it seems RVX doesn't have a real good handle on it and why (go back to the above point)...

...now i give you all this tidbit, on the goofy TST MB, the bagholder brigade there is cheering like crazy that the FDA waved the filing fee for TST, except the bagholders have so little knowledge (and attack people like me who try to help them out) as to not know that the #1 predictor of whether a BLA or NDA gets approved is the fee waiver (comanpies who got a waiver had a 87% failure rate i believe) and they also are small, foreign, with no previous FDA approved trials and limited FDA experience...how does RVX fit that profile...they shoulda given Newton anything to take over, instead he left formed ESPR and the rest is history..

...westcoasts party lament about the "in" crowd never having heard of RVX and that failure to partner is a big tell is well a big tell (chinee thing for money ain't a partner) and PS if 208 was in-licensed by a US biotech or BP that predicts one of the highest % chance of approval..

..hope this helps others...i view RVX as a trade not a long term investment, get a new CEO and i would rethink..and ps your idiocy about Dart, he is protected like no other shoudl RVX fail
Bullboard Posts